Share price: 105.25p

INTERIM RESULTS

16th September 2008

Interim headline operating profit up 33% to £4.4m

Cello today announces its interim results for the six month period to 30 June 2008.

Highlights

 

    Turnover up 44% to £66.1m (2007: £45.8m)
    Operating income up 39% to £33.9m (2007: £24.4m)
    Headline operating profit up 33% to £4.4m (2007: £3.3m)
    Like-for-like operating income growth of 5%
    Basic headline earnings per share up 7% to 6.84p (2007: 6.42p)
    Interim dividend up 11% to 0.50p (2007: 0.45p)
    Largest single earnout settlement of £14.4m completed through a mix of cash and shares, representing 43% of outstanding earnout provisions
    Re-branding and consolidation of Tangible underpins strong performance
    Cello Research and Consulting ranked 10th in the UK* and 21st globally**
    Tangible ranked 6th in the UK***

    Mark Scott, Chief Executive, commented:

    “We saw a strong performance in the first half of 2008 with the focus being on consolidation after three years of acquisition. Both our research business and our response business have now emerged as major operators in their respective markets, competing for the largest contracts previously the preserve of long established global incumbents. We now face the more challenging macro environment in a strong position, with an excellent client list, a focused group of professionals and a strong balance sheet.”

    source: *Marketing Sept 2008 **Marketing News August 2008 ***Marketing April 2008

     

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150